SCHEMBL19821145

SCHEMBL19821145

CNC[C@H]1OCCc2ccc(C)cc21

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 6/20 0.56
HTR1A P08908 1/20 0.51
DRD2 P14416 1/20 0.51
HTR7 P34969 1/20 0.51
XBP1 P17861 1/20 0.45
ALDH1A1 P00352 5/20 0.43
KMT2A Q03164 2/20 0.39
LMNA P02545 1/20 0.39
GAA P10253 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
TSHR P16473 1/20 0.39
RECQL P46063 1/20 0.39
ADRA2A P08913 1/20 0.38
ADRA2B P18089 1/20 0.38
ADRA2C P18825 1/20 0.38
ADRA1D P25100 1/20 0.38
ADRA1A P35348 1/20 0.38
ADRA1B P35368 1/20 0.38
THRB P10828 1/20 0.38
CYP1A2 P05177 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19821146 1.00 TAAR1 (0.56) TAAR1HTR1ADRD2HTR7XBP1
SCHEMBL19821147 0.88 TAAR1 (0.56) TAAR1HTR1ADRD2HTR7XBP1
SCHEMBL19831964 0.88 TAAR1 (0.56) TAAR1HTR1ADRD2HTR7XBP1
SCHEMBL19821151 0.88 TAAR1 (0.56) TAAR1HTR1ADRD2HTR7XBP1
SCHEMBL19812798 0.84 TAAR1 (0.55) TAAR1HTR1ADRD2HTR7ALDH1A1
SCHEMBL19812903 0.84 TAAR1 (0.55) TAAR1HTR1ADRD2HTR7ALDH1A1
SCHEMBL20700250 0.84 TAAR1 (0.55) TAAR1HTR1ADRD2HTR7XBP1
SCHEMBL20703566 0.84 TAAR1 (0.55) TAAR1HTR1ADRD2HTR7XBP1
SCHEMBL32670576 0.84 TAAR1 (0.55) TAAR1HTR1ADRD2HTR7ALDH1A1
SCHEMBL19812796 0.84 TAAR1 (0.55) TAAR1HTR1ADRD2HTR7ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180030064-A1 COMPOUNDS AND COMPOSITIONS AND USES THEREOF SUMITOMO PHARMA AMERICA, INC. 2018-02-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180030064-A1 COMPOUNDS AND COMPOSITIONS AND USES THEREOF CHAT, ACHE, MAOB TAAR1 893/4885HTR1A 207/4885DRD2 336/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.